Identifying Diagnosis of a Pandemic COVID-19
Author(s): Sirjan Singh*, Vasant Wagh and Swarupa Chakole
Abstract
In December 2019, the Coronavirus Disease (COVID-19) was found in Hubei Province, China. SARS-CoV-2 is a virus affecting respiratory system that causes coryza like symptoms along with risk of SARS in many. Moreover, investigation of these deadly disease patients has unveiled that the virus can cause symptoms hampering systems other than respiratory. For pandemic prevention and control, prompt and on point spotting of SARS CoV-2 infestation is crucial. Determination can help contain COVID-19 by allowing for quick deployment of control measures such patient recognition, segregation, and contact tracing. The quick and secure recognition of SARS CoV-2, facilitated by active Reverse Transcription–Polymerase Chain Reaction (RT–PCR), is the initial leap to managing COVID-19. Given the benefits and limits of present diagnostics platforms, as well as their solitary result merits, scrutinizing outcomes must be thoroughly reviewed prior to reaching decisions in clinical and non-clinical situations. Conclusion: COVID-19 diagnostic testing is critical for detecting the virus, apprehension of its epidemiology, managing cases, and preventing transmission. Future efforts to build novel diagnostic platforms could pay off if the scrutiny are exact and simple to implement, deliver outcomes quickly, and are inexpensive to mass distribute. Given the benefits and limits of present scrutiny platforms, as well as their solitary result values, testing outcomes must be thoroughly reviewed before putting it out in clinical and non-clinical situations. In the regards to disease transmission and prevention, this Review provides a thorough ladder for diagnostic strategies. It's a basic scientific primer.